Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126082921 | 12608292 | 1 | I | 20160722 | 20160729 | 20160729 | PER | US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-48287BP | BOEHRINGER INGELHEIM | 0.00 | F | Y | 0.00000 | 20160729 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126082921 | 12608292 | 1 | PS | PRADAXA | DABIGATRAN ETEXILATE MESYLATE | 1 | Oral | 300 MG | Y | 22512 | 150 | MG | CAPSULE | BID |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126082921 | 12608292 | 1 | Cardiovascular disorder |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126082921 | 12608292 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126082921 | 12608292 | Anxiety | |
126082921 | 12608292 | Confusional state | |
126082921 | 12608292 | Depression | |
126082921 | 12608292 | Feeling abnormal | |
126082921 | 12608292 | Gait disturbance | |
126082921 | 12608292 | Haemorrhage | |
126082921 | 12608292 | Hypoacusis | |
126082921 | 12608292 | Memory impairment | |
126082921 | 12608292 | Off label use |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |